ABT Abbott Laboratories stock chart & analysis
Conviction 40HealthcareScan · Fri, Nov 6, 2026Abbott Laboratories (ABT) closed at $109.93 (-3.23%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 59, RS Rating 46, -16.7% from its 52-week high, -12.2% year to date. Sector: Healthcare · Pharmaceutical Preparations.
Financials as of Wed, Sep 30, 2026 · quarterly.
ABT technical analysis
Trend
ABT is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 5.7% above the 50-day ($104.01) and 8.3% above the 200-day ($101.51). ADX(14) at 23 points to a moderate trend. It meets 5 of 8 trend-template criteria.
Momentum
RSI(14) is 59, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 46 puts its weighted 12-month performance ahead of about 46% of the US market.
Volume and volatility
Volume on the latest session ran 0.6× its 20-day average. It trades about $1.0B a day on average. ATR(14) is $3.18, 2.9% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.13) shows accumulation.
Key levels
The chart pattern's support is $96.13 and its resistance $105.82. The 52-week range is $81.97 to $132.03; price is 16.7% below the high and 34.2% above the low. The VWAP anchored at the 52-week high is $103.26, below price.
Performance
ABT returned +3.5% (1 week), +11.7% (1 month), +1.2% (3 months), +30.4% (6 months), -11.7% (1 year), -12.2% (year to date).
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Pharmaceutical Preparations · Listed 1949 · 115,000 employees
Congress activity
Disclosed STOCK Act trades in ABT · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Thomas H. Kean house · R · NJ · traded 2026-09-17 | Sell | $1K–$15K | 2026-09-17 | 2026-10-30 | |
 Pete Sessions house · R · TX · traded 2026-10-02 | Sell | $50K–$100K | 2026-10-02 | 2026-10-27 | |
 Gilbert Cisneros house · D · CA · traded 2026-09-18 | Buy | $1K–$15K | 2026-09-18 | 2026-10-12 | |
 Richard W. Allen house · GA · traded 2026-07-14 | Sell | $15K–$50K | 2026-07-14 | 2026-08-18 | |
 Richard Dean Dr McCormick house · R · GA · traded 2026-07-30 | Sell | $1K–$15K | 2026-07-30 | 2026-08-14 | |
 Mike Kelly house · R · PA · traded 2026-07-17 | Sell | $1K–$15K | 2026-07-17 | 2026-08-12 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Sell | $15K–$50K | 2026-03-27 | 2026-07-21 | |
 Rick Larsen house · D · WA · traded 2026-07-08 | Sell | $1K–$15K | 2026-07-08 | 2026-07-12 | |
Richard Dean Dr McCormick house · R · GA · traded 2026-06-12 | Buy | $1K–$15K | 2026-06-12 | 2026-07-09 | |
Gilbert Cisneros house · D · CA · traded 2026-06-16 | Buy | $1K–$15K | 2026-06-16 | 2026-07-02 |
Insider activity
SEC Form 4 transactions in ABT · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Moreland Mary K EXECUTIVE VICE PRESIDENT · Common shares without par value · 2026-11-05 | Sell | 3.5K | $406K | 2026-11-05 | 2026-11-06 |
Ahuja Nita Director · Stock Equivalent Units · 2026-09-30 | Grant | 318 | $31K | 2026-09-30 | 2026-10-02 |
Roman Michael F Director · Stock Equivalent Units · 2026-09-30 | Grant | 381 | $38K | 2026-09-30 | 2026-10-02 |
Conroy Kevin T Director · Stock Equivalent Units · 2026-09-30 | Grant | 318 | $31K | 2026-09-30 | 2026-10-02 |
Gonzalez Patricia Paola Director · Stock Equivalent Units · 2026-09-30 | Grant | 333 | $33K | 2026-09-30 | 2026-10-02 |
Stratton John G Director · Stock Equivalent Units · 2026-09-30 | Grant | 397 | $39K | 2026-09-30 | 2026-10-02 |
Ford Robert B CHAIRMAN AND CEO · Common shares without par value · 2026-08-25 | Sell | 218.53K | $25M | 2026-08-25 | 2026-08-27 |
Ford Robert B CHAIRMAN AND CEO · Common shares without par value · 2026-08-25 | Exercise | 151.87K | $6.7M | 2026-08-25 | 2026-08-27 |
Ford Robert B CHAIRMAN AND CEO · Common shares without par value · 2026-08-25 | Exercise | 246.96K | $15M | 2026-08-25 | 2026-08-27 |
Ford Robert B CHAIRMAN AND CEO · Common shares without par value · 2026-08-25 | Sell | 180.3K | $21M | 2026-08-25 | 2026-08-27 |
SEC filings
EDGAR filings in ABT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.